Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

NNIT

DB:5NN
Snowflake Description

Flawless balance sheet and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
5NN
DB
DKK3B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

NNIT A/S provides a range of IT services and solutions to customers primarily in the life sciences sector in Denmark and internationally. The last earnings update was 69 days ago. More info.


Add to Portfolio Compare Print
  • NNIT has significant price volatility in the past 3 months.
5NN Share Price and Events
7 Day Returns
19.4%
DB:5NN
16.8%
DE Healthcare Services
2.1%
DE Market
1 Year Returns
-47.2%
DB:5NN
15.8%
DE Healthcare Services
-16.6%
DE Market
5NN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
NNIT (5NN) 19.4% -10.2% -13.5% -47.2% -49% -42.8%
DE Healthcare Services 16.8% 4.4% -1.9% 15.8% 50.3% 117%
DE Market 2.1% -12.6% -22.9% -16.6% -21.9% -27.8%
1 Year Return vs Industry and Market
  • 5NN underperformed the Healthcare Services industry which returned 15.8% over the past year.
  • 5NN underperformed the Market in Germany which returned -16.6% over the past year.
Price Volatility
5NN
Industry
5yr Volatility vs Market
Related Companies

5NN Value

 Is NNIT undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of NNIT to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for NNIT.

DB:5NN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 4.8%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:5NN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.79
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.794 (1 + (1- 22%) (22.12%))
0.953
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.95
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (0.953 * 5.44%)
4.8%

Discounted Cash Flow Calculation for DB:5NN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for NNIT is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:5NN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (DKK, Millions) Source Present Value
Discounted (@ 4.8%)
2020 270.00 Analyst x1 257.64
2021 220.00 Analyst x2 200.32
2022 274.00 Analyst x1 238.07
2023 278.40 Est @ 1.61% 230.82
2024 281.20 Est @ 1.01% 222.47
2025 282.86 Est @ 0.59% 213.54
2026 283.69 Est @ 0.29% 204.36
2027 283.94 Est @ 0.09% 195.18
2028 283.79 Est @ -0.05% 186.15
2029 283.35 Est @ -0.16% 177.35
Present value of next 10 years cash flows DKK2,125.00
DB:5NN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= DKK283.35 × (1 + -0.39%) ÷ (4.8% – -0.39%)
DKK5,441.46
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= DKK5,441.46 ÷ (1 + 4.8%)10
DKK3,405.90
DB:5NN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= DKK2,125.00 + DKK3,405.90
DKK5,530.90
Equity Value per Share
(DKK)
= Total value / Shares Outstanding
= DKK5,530.90 / 24.54
DKK225.42
DB:5NN Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:5NN represents 0.11633x of CPSE:NNIT
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.11633x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (DKK) x Listing Adjustment Factor
= DKK 225.42 x 0.11633
€26.22
Value per share (EUR) From above. €26.22
Current discount Discount to share price of €12.54
= -1 x (€12.54 - €26.22) / €26.22
52.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price NNIT is available for.
Intrinsic value
>50%
Share price is €12.54 vs Future cash flow value of €26.22
Current Discount Checks
For NNIT to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • NNIT's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • NNIT's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for NNIT's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are NNIT's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:5NN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in DKK DKK7.43
CPSE:NNIT Share Price ** CPSE (2020-04-07) in DKK DKK107.8
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.51x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 16.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of NNIT.

DB:5NN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CPSE:NNIT Share Price ÷ EPS (both in DKK)

= 107.8 ÷ 7.43

14.51x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NNIT is overvalued based on earnings compared to the DE Healthcare Services industry average.
  • NNIT is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does NNIT's expected growth come at a high price?
Raw Data
DB:5NN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 14.51x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
2.1%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.68x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.22x

*Line of best fit is calculated by linear regression .

DB:5NN PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 14.51x ÷ 2.1%

6.91x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NNIT is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on NNIT's assets?
Raw Data
DB:5NN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in DKK DKK47.57
CPSE:NNIT Share Price * CPSE (2020-04-07) in DKK DKK107.8
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.82x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.45x
DB:5NN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CPSE:NNIT Share Price ÷ Book Value per Share (both in DKK)

= 107.8 ÷ 47.57

2.27x

* Primary Listing of NNIT.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NNIT is good value based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess NNIT's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. NNIT has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

5NN Future Performance

 How is NNIT expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
2.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is NNIT expected to grow at an attractive rate?
  • NNIT's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • NNIT's earnings growth is positive but not above the Germany market average.
  • NNIT's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:5NN Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:5NN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 2.1%
DB:5NN Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 1.2%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.9%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:5NN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in DKK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:5NN Future Estimates Data
Date (Data in DKK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 3,153 1
2023-12-31 3,066 1
2022-12-31 2,989 440 185 2
2021-12-31 2,890 396 172 2
2020-12-31 2,875 428 142 1
2020-04-07
DB:5NN Past Financials Data
Date (Data in DKK Millions) Revenue Cash Flow Net Income *
2019-12-31 3,058 465 183
2019-09-30 3,080 373 209
2019-06-30 3,050 391 208
2019-03-31 3,059 292 230
2018-12-31 3,007 439 236
2018-09-30 2,964 318 224
2018-06-30 2,892 315 199
2018-03-31 2,835 367 189
2017-12-31 2,851 425 199
2017-09-30 2,841 442 198
2017-06-30 2,854 434 226
2017-03-31 2,817 416 220

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • NNIT's earnings are expected to grow by 2.1% yearly, however this is not considered high growth (20% yearly).
  • NNIT's revenue is expected to grow by 1.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:5NN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from NNIT Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:5NN Future Estimates Data
Date (Data in DKK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31 7.64 7.64 7.64 1.00
2021-12-31 7.04 7.10 6.98 2.00
2020-12-31 5.86 5.86 5.86 1.00
2020-04-07
DB:5NN Past Financials Data
Date (Data in DKK Millions) EPS *
2019-12-31 7.43
2019-09-30 8.51
2019-06-30 8.46
2019-03-31 9.37
2018-12-31 9.60
2018-09-30 9.14
2018-06-30 8.12
2018-03-31 7.73
2017-12-31 8.17
2017-09-30 8.14
2017-06-30 9.29
2017-03-31 9.10

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • NNIT is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess NNIT's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
NNIT has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

5NN Past Performance

  How has NNIT performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare NNIT's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • NNIT's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • NNIT's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • NNIT's 1-year earnings growth is negative, it can't be compared to the DE Healthcare Services industry average.
Earnings and Revenue History
NNIT's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from NNIT Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:5NN Past Revenue, Cash Flow and Net Income Data
Date (Data in DKK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 3,058.00 183.00 236.00
2019-09-30 3,079.74 209.31 226.07
2019-06-30 3,049.77 207.80 223.51
2019-03-31 3,058.67 230.02 228.18
2018-12-31 3,007.15 235.61 227.80
2018-09-30 2,964.01 223.75 243.23
2018-06-30 2,892.24 198.50 250.11
2018-03-31 2,834.78 188.65 250.87
2017-12-31 2,851.39 198.82 252.68
2017-09-30 2,840.53 198.15 243.92
2017-06-30 2,853.53 225.88 242.47
2017-03-31 2,817.08 220.41 242.65
2016-12-31 2,764.59 215.70 242.86
2016-09-30 2,718.65 211.63 265.09
2016-06-30 2,677.17 211.19 268.99
2016-03-31 2,647.57 205.60 267.60
2015-12-31 2,600.29 212.44 264.39
2015-09-30 2,566.13 215.78 249.78
2015-06-30 2,520.23 217.89 241.37
2015-03-31 2,473.73 223.10 229.69
2014-12-31 2,410.40 209.28 224.32
2014-09-30 2,333.79 206.33 223.12
2014-06-30 2,289.43 196.52 214.40
2014-03-31 2,256.76 199.23 215.06
2013-12-31 2,204.53 185.57 211.37
2013-09-30 2,176.82 172.70 209.58
2013-06-30 2,126.26 165.26 208.92

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • NNIT has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • NNIT used its assets less efficiently than the DE Healthcare Services industry average last year based on Return on Assets.
  • NNIT's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess NNIT's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
NNIT has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

5NN Health

 How is NNIT's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up NNIT's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • NNIT is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • NNIT's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of NNIT's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 4.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from NNIT Company Filings, last reported 3 months ago.

DB:5NN Past Debt and Equity Data
Date (Data in DKK Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 1,169.00 259.00 122.00
2019-09-30 1,100.07 492.96 100.82
2019-06-30 1,096.82 417.57 100.21
2019-03-31 1,068.08 330.79 76.71
2018-12-31 1,084.93 242.68 107.55
2018-09-30 990.44 201.12 83.62
2018-06-30 990.91 183.79 82.55
2018-03-31 928.61 0.00 7.18
2017-12-31 973.57 93.19 88.53
2017-09-30 907.65 67.68 74.36
2017-06-30 926.93 0.00 109.21
2017-03-31 860.51 0.00 272.70
2016-12-31 846.47 0.00 192.11
2016-09-30 758.14 0.00 124.96
2016-06-30 749.66 0.00 160.12
2016-03-31 698.64 0.00 192.50
2015-12-31 740.82 0.00 180.34
2015-09-30 665.58 24.64 111.58
2015-06-30 608.99 94.71 100.53
2015-03-31 579.21 74.89 79.79
2014-12-31 684.25 0.00 152.68
2014-09-30 613.81 0.00 108.25
2014-06-30 710.63 0.00 155.78
2014-03-31 669.26 0.00 132.61
2013-12-31 765.34 0.00 284.03
2013-09-30 690.00 0.00 130.04
2013-06-30 648.49 0.00 28.42
  • NNIT's level of debt (22.2%) compared to net worth is satisfactory (less than 40%).
  • NNIT had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
  • Debt is well covered by operating cash flow (179.5%, greater than 20% of total debt).
  • NNIT earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess NNIT's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. NNIT has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

5NN Dividends

 What is NNIT's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
3.71%
Current annual income from NNIT dividends. Estimated to be 2.95% next year.
If you bought €2,000 of NNIT shares you are expected to receive €74 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • NNIT's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.67%).
  • NNIT's dividend is below the markets top 25% of dividend payers in Germany (4.71%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:5NN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.7%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 4.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:5NN Future Dividends Estimate Data
Date (Data in DKK) Dividend per Share (annual) Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31 3.44 1.00
2021-12-31 3.19 2.00
2020-12-31 2.90 1.00
2020-04-07
DB:5NN Past Annualized Dividends Data
Date (Data in DKK) Dividend per share (annual) Avg. Yield (%)
2020-01-29 4.000 4.198
2019-08-13 4.600 5.153
2019-03-07 4.600 3.391
2018-05-15 4.300 2.439
2018-01-25 4.300 2.437
2017-08-16 4.200 2.310
2017-03-08 4.400 2.236
2016-10-26 4.000 2.057
2016-08-16 4.000 1.840
2016-01-27 4.000 2.034

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • NNIT has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • NNIT has only been paying a dividend for 4 years, and since then there has been no growth.
Current Payout to shareholders
What portion of NNIT's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.9x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (2.2x coverage).
X
Income/ dividend checks
We assess NNIT's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can NNIT afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. NNIT has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

5NN Management

 What is the CEO of NNIT's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Per Kogut
COMPENSATION DKK12,331,000
TENURE AS CEO 13.3 years
CEO Bio

Mr. Per Kogut has been the Chief Executive Officer of NNIT A/S since 2007 and serves as its President and Member of the Executive Management. Mr. Kogut joined NNIT in January 2007. He served as the Chief Executive Officer of CA Northern Europe. He served as Member of the Senior Management Board for Novo Nordisk A/S since January 2007. He serves as Chairman of the Board of Netgroup A/S. He serves as a Member of the Board of Tee TopCo A/S (EET Europarts) and Danish IT Industry Association (ITB). Mr. Kogut holds an M.Sc. in Political Science from the University of Copenhagen.

CEO Compensation
  • Per's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Per's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the NNIT management team in years:

3.8
Average Tenure
  • The tenure for the NNIT management team is about average.
Management Team

Per Kogut

TITLE
President & CEO
COMPENSATION
DKK12M
TENURE
13.3 yrs

Carsten Thomsen

TITLE
Executive VP of Finance
COMPENSATION
DKK7M
AGE
62
TENURE
6.3 yrs

Jens Binger

TITLE
Head of Investor Relations

Rikke Dalager

TITLE
Head of Communications

Brit Kannegaard-Johannessen

TITLE
Senior Vice President of People
TENURE
1.3 yrs

Jacob Michelsen

TITLE
Senior Vice President of Private & Public
TENURE
4.3 yrs

Ricco Larsen

TITLE
Senior Vice President of Life Sciences
TENURE
3.3 yrs

Claus Andersen

TITLE
Senior Vice President of Projects & Consulting
TENURE
2.4 yrs

Søren Østergaard

TITLE
Senior Vice President of Infrastructure & Application Services
TENURE
2.4 yrs

Jan Weber

TITLE
General Manager of North American Affiliate
TENURE
4.4 yrs
Board of Directors Tenure

Average tenure and age of the NNIT board of directors in years:

3.1
Average Tenure
57
Average Age
  • The tenure for the NNIT board of directors is about average.
Board of Directors

Carsten Dilling

TITLE
Independent Chairman
COMPENSATION
DKK750K
AGE
57
TENURE
3.3 yrs

Peter Haahr

TITLE
Deputy Chairman
COMPENSATION
DKK450K
AGE
51
TENURE
3.1 yrs

Anne Broeng

TITLE
Independent Director
COMPENSATION
DKK450K
AGE
58
TENURE
6.3 yrs

Eivind Kolding

TITLE
Independent Director
COMPENSATION
DKK375K
AGE
60
TENURE
5.1 yrs

Anders Vidstrup

TITLE
Employee Representative Director
COMPENSATION
DKK300K
AGE
57
TENURE
5.3 yrs

Christian Kanstrup

TITLE
Director
COMPENSATION
DKK356K
AGE
47
TENURE
2.1 yrs

Caroline Serfass

TITLE
Independent Director
COMPENSATION
DKK374K
AGE
58
TENURE
2.1 yrs

Brankica Markovic

TITLE
Employee Representative Director
TENURE
1.1 yrs

Trine Bjerregaard

TITLE
Employee Representative Director
TENURE
1.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess NNIT's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. NNIT has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

5NN News

Simply Wall St News

5NN Company Info

Description

NNIT A/S provides a range of IT services and solutions to customers primarily in the life sciences sector in Denmark and internationally. The company provides advisory services comprising IT organization optimization, outsourcing, organization change management, IT project excellence, security and compliance consulting, mobility, digital transformation, and robotic process automation services. It also offers business solutions, which include life science solutions; enterprise resource planning (ERP) and ERP transformation services; portals and collaborations; enterprise content management, and information and supply chain management solutions. In addition, the company provides application outsourcing solutions, such as network and local delivery, ERP outsourcing, portals outsourcing and collaboration, and platform-as-a-service. Further, it offers infrastructure outsourcing services, including business critical hosting, network management, device management, security and compliance management, and middleware integration services; infrastructure-as-a-service; and service desk, application support, and onsite support services. The company serves the public, enterprise, and finance sector customers. NNIT A/S was founded in 1994 and is headquartered in Soborg, Denmark.

Details
Name: NNIT A/S
5NN
Exchange: DB
Founded: 1994
DKK354,124,727
24,535,907
Website: http://www.nnit.com
Address: NNIT A/S
Oestmarken 3A,
Soborg,
Capital Region of Denmark, 2860,
Denmark
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CPSE NNIT Ordinary Shares OMX Nordic Exchange Copenhagen DK DKK 06. Mar 2015
DB 5NN Ordinary Shares Deutsche Boerse AG DE EUR 06. Mar 2015
LSE 0R5Z Ordinary Shares London Stock Exchange GB DKK 06. Mar 2015
BATS-CHIXE NNITC Ordinary Shares BATS 'Chi-X Europe' GB DKK 06. Mar 2015
Number of employees
Current staff
Staff numbers
3,207
NNIT employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 23:47
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/03/31
Last earnings filing: 2020/01/29
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.